Besides, overexpression of FTO in acute myeloid leukemia cells could decrease m6A modification of NANOG and SOX2 and increase their mRNA levels,51 which was consistent with our studies in HCC cells. The gene discussed is FTO; the disease is hepatocellular carcinoma.